news
-
19 October 2022Sonendo, Inc. to Report Third Quarter 2022 Financial Results on November 9, 2022
Sonendo, Inc. (“Sonendo”) (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced that it will report financial results for the third quarter 2022 after the market close on Wednesday, November 9th, 2022. Management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results.
Investors interested in listening to the conference call may do so by dialing (844) 200-6205 for domestic callers or (929) 526-1599 for international callers, using access code: 579984. Live audio of the webcast will be available at: https://investor.sonendo.com.
An archived recording will be available on the “Investors” section of the company’s website at: https://investor.sonendo.com. The webcasts will be available for replay for at least 90 days after the event.
Related
Sonendo® Announces Next Generation GentleWave® G4 System
Sonendo, Inc. Announces $63 Million Private Placement
Sonendo, Inc. Reports Second Quarter 2022 Financial Results
Sonendo, Inc. Welcomes Joanne Lindberg as Vice President of Sales, North America
Sonendo, Inc. Announces Executive Management Team Changes
Sonendo, Inc. Reports First Quarter 2022 Financial Results
Sonendo Announces Launch of CleanFlow™ Technology to Improve Doctor and Patient Experience
Sonendo, Inc. to Report Fourth Quarter and Full Year 2021 Financial Results on March 23, 2022
Sonendo, Inc. Announces Preliminary Revenue Results for the Fourth Quarter and Full-Year 2021
Sonendo Inc. Reports Third Quarter 2021 Financial Results and Issues Full Year 2021 Revenue Guidance
Sonendo, Inc. Announces Pricing of Initial Public Offering
Sonendo, Inc. Announces Launch of Initial Public Offering
Sonendo®, Inc. Announces Filing of Registration Statement for Proposed Initial Public Offering
Sonendo® Acquires Portfolio of Novel Dental Procedure Technology Patents
Sonendo® Launches 500K Club Charitable Initiative
Sonendo® Reaches 500,000 Patients Treated Milestone with the GentleWave® Procedure
Sonendo® Appoints Amit Agarwal as Vice President of Marketing
Sonendo® Appoints Andrew Kirkpatrick as Chief Operating Officer
Sonendo® Announces Growth Investment from EW Healthcare Partners
Sonendo® Ships a Record 200,000 GentleWave® Procedure Instruments
Sonendo® to Launch the GentleWave® System in Canada at AAE 2019
Sonendo® and TDO® Software Expand Their Strategic Partnership
Sonendo® Named Fastest Growing Mid-Size Private Company in Orange County
Sonendo® Announces GentleWave® System Integration With TDO® Endodontic Software
Sonendo® Ships 50,000 GentleWave® Procedure Instruments to Endodontists
Sonendo® appoints Michael Watts as Chief Financial Officer
Sonendo® 2017 Red Herring Top 100 Global Winner
Sonendo® wins Octane High Tech Innovation Award
Sonendo® announces growth investment from General Atlantic
Sonendo® 2017 Red Herring Top 100 North America Winner In Medical Device Category
Sonendo® Acquires Pipstek™ LLC
Sonendo® Closes $35 Million Equity Financing Round
Sonendo® appoints John "Jack" Glenn as Chief Financial Officer
Prospective multicenter study shows remarkable healing rates with Sonendo's Gentlewave® System
Sonendo's GentleWave® System finalist in the 2016 Medical Design Excellence Awards
Sonendo® receives FDA 510(K) clearance for the next generation of the Gentlewave® System
Sonendo® Appoints Chief Commercial Officer
Sonendo® Appoints Vice President of Operations
Sonendo® Receives 510(k) FDA Clearance For Its Multisonic Ultracleaning™System
Sonendo® Closes $35 Million Equity Financing Round
Sonendo® Receives 510(k) FDA Clearance For Its Multisonic Ultracleaning System
Sonendo® Closes $10 Million Venture Debt Facility with Oxford Finance
Sonendo® Receives 510(k) FDA Clearance For Its Multisonic Ultracleaning System™
Sonendo completes second round totaling $27 million
Sonendo® Debuts New Endodontic Multisonic Ultracleaning™ System at AAE 2013 Hawaii
Sonendo Agrees To Terms For Up To $20 Million In Financing